SE510305C2 - Nytt salt - Google Patents
Nytt saltInfo
- Publication number
- SE510305C2 SE510305C2 SE9702066A SE9702066A SE510305C2 SE 510305 C2 SE510305 C2 SE 510305C2 SE 9702066 A SE9702066 A SE 9702066A SE 9702066 A SE9702066 A SE 9702066A SE 510305 C2 SE510305 C2 SE 510305C2
- Authority
- SE
- Sweden
- Prior art keywords
- salt
- tartrate
- benzopyran
- dihydro
- fluoro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (36)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9702066A SE510305C2 (sv) | 1997-05-30 | 1997-05-30 | Nytt salt |
TW087107397A TW510899B (en) | 1997-05-30 | 1998-05-13 | A salt (R)-3-N,N-dicyclobutyamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrogen (2R,3R)-tartrate, a pharmaceutical composition containing said salt and a process for the manufacture of said salt |
JP50056099A JP3554338B2 (ja) | 1997-05-30 | 1998-05-15 | 新規な塩 |
IL13323498A IL133234A (en) | 1997-05-30 | 1998-05-15 | Hydrogen Tartrate of (R) - 3 (N, N-Dicyclobutyl-Amino) - 8 Fluoro-4,3 Dihydro 1 H2-Benzopyran-5-Carboxamide, process for its preparation and pharmaceutical preparations containing it |
PT98925993T PT984952E (pt) | 1997-05-30 | 1998-05-15 | Novo sal |
YU62499A YU62499A (sh) | 1997-05-30 | 1998-05-15 | Nova so |
UA99127241A UA53720C2 (uk) | 1997-05-30 | 1998-05-15 | Кислий (2r,3r)-тартрат (r)-3-n,n-дициклоаміно-8-фтор-3,4-дигідро-2н-1-бензопіран-5-карбоксаміду, його моногідрат, спосіб їх одержання та фармацевтична композиція |
CA002291732A CA2291732C (en) | 1997-05-30 | 1998-05-15 | A salt (r)-3-n,n-dicyclobutylamino-8-fluoro-3,4-dihydro-2h-1-benzopyran-5-carboxaminde hydrogen (2r,3r)-tartrate |
DK98925993T DK0984952T3 (da) | 1997-05-30 | 1998-05-15 | Hidtil ukendt salt |
TR1999/02926T TR199902926T2 (xx) | 1997-05-30 | 1998-05-15 | Yeni bir tuz. |
SK1594-99A SK282755B6 (sk) | 1997-05-30 | 1998-05-15 | Soľ karboxamidhydrogenvínan, spôsob jej prípravy, farmaceutický prípravok s jej obsahom a jej použitie |
US09/077,718 US6858645B2 (en) | 1997-05-30 | 1998-05-15 | Tartrate salts of (R) -3-N,N- dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1- benzopyran-5-carboxamide |
IDW991407A ID23794A (id) | 1997-05-30 | 1998-05-15 | Proses, pembuatan dan penggunaan garam bentuk (2r, 3r) tartrat |
EEP199900549A EE03874B1 (et) | 1997-05-30 | 1998-05-15 | (R)-3-N,N-ditsüklobutüülamino-8-fluoro-3,4-dihüdro-2H-1-bensopüraan-5-karboksam iidvesinik- tartraat, selle valmistamise meetod ja seda sisaldav ravimkoostis |
SI9830332T SI0984952T1 (en) | 1997-05-30 | 1998-05-15 | A new salt |
HU0001878A HUP0001878A3 (en) | 1997-05-30 | 1998-05-15 | (r)-3-(n,n-dicyclobutyl-amino)-8-fluoro-3,4-dihydro-2h-1-benzopyran-5-carboxamide hydrogen tartrate, process for its preparation and pharmatceutical compositions of the same |
NZ501075A NZ501075A (en) | 1997-05-30 | 1998-05-15 | (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrogen (2R,3R)-tartrate |
ES98925993T ES2187030T3 (es) | 1997-05-30 | 1998-05-15 | Una nueva sal. |
RU99128026/04A RU2193560C2 (ru) | 1997-05-30 | 1998-05-15 | Новая соль |
BR9809519-6A BR9809519A (pt) | 1997-05-30 | 1998-05-15 | Sal, processo para fabricação e uso do mesmo, formulação farmacêutica, e, processo para prevenção ou tratamento de distúrbios cns e perturbações médicas relacionadas |
PCT/SE1998/000907 WO1998054166A1 (en) | 1997-05-30 | 1998-05-15 | A new salt |
CNB988056631A CN1198814C (zh) | 1997-05-30 | 1998-05-15 | 一种新的盐 |
AT98925993T ATE228121T1 (de) | 1997-05-30 | 1998-05-15 | Neues salz |
PL98337181A PL337181A1 (en) | 1997-05-30 | 1998-05-15 | Novel salt |
EP98925993A EP0984952B1 (en) | 1997-05-30 | 1998-05-15 | A new salt |
DE69809547T DE69809547T2 (de) | 1997-05-30 | 1998-05-15 | Neues salz |
KR19997011107A KR20010013127A (ko) | 1997-05-30 | 1998-05-15 | 신규 염 |
AU77923/98A AU729301B2 (en) | 1997-05-30 | 1998-05-15 | A new salt |
ZA984486A ZA984486B (en) | 1997-05-30 | 1998-05-26 | A new salt |
ARP980102434A AR012751A1 (es) | 1997-05-30 | 1998-05-26 | Sales de hidrogeno tartrato de (r) -3-n,n-diciclobutilamino-8-fluoro-3,4 -dihidro-2h-1-benzopiran-5-carboxamida, su uso para la fabricacion de medicamentos para tratar trastornos de snc y trastornos medicos relacionados y procedimiento para la fabricacion de dichas sales |
MYPI98002400A MY117960A (en) | 1997-05-30 | 1998-05-29 | A new salt |
IS5270A IS1943B (is) | 1997-05-30 | 1999-11-24 | (R)-3-N,N-dísýklóbútýlamínó-8-flúor-3,4-díhýdró-2H-1-bensópýran-5-karboxamíðhýdrógentartrat, aðferðvið framleiðslu þess og lyfjablöndur sem innihalda það |
NO995853A NO995853L (no) | 1997-05-30 | 1999-11-29 | Nytt salt |
BG103949A BG64051B1 (bg) | 1997-05-30 | 1999-12-03 | Нова сол |
HK00104934A HK1025575A1 (en) | 1997-05-30 | 2000-08-08 | A new salt |
US10/964,388 US20050085532A1 (en) | 1997-05-30 | 2004-10-12 | Tartrate salts of (R)-3-N,N-dicyclo-butylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9702066A SE510305C2 (sv) | 1997-05-30 | 1997-05-30 | Nytt salt |
Publications (3)
Publication Number | Publication Date |
---|---|
SE9702066D0 SE9702066D0 (sv) | 1997-05-30 |
SE9702066L SE9702066L (sv) | 1998-12-01 |
SE510305C2 true SE510305C2 (sv) | 1999-05-10 |
Family
ID=20407187
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9702066A SE510305C2 (sv) | 1997-05-30 | 1997-05-30 | Nytt salt |
Country Status (34)
Country | Link |
---|---|
US (2) | US6858645B2 (xx) |
EP (1) | EP0984952B1 (xx) |
JP (1) | JP3554338B2 (xx) |
KR (1) | KR20010013127A (xx) |
CN (1) | CN1198814C (xx) |
AR (1) | AR012751A1 (xx) |
AT (1) | ATE228121T1 (xx) |
AU (1) | AU729301B2 (xx) |
BG (1) | BG64051B1 (xx) |
BR (1) | BR9809519A (xx) |
CA (1) | CA2291732C (xx) |
DE (1) | DE69809547T2 (xx) |
DK (1) | DK0984952T3 (xx) |
EE (1) | EE03874B1 (xx) |
ES (1) | ES2187030T3 (xx) |
HK (1) | HK1025575A1 (xx) |
HU (1) | HUP0001878A3 (xx) |
ID (1) | ID23794A (xx) |
IL (1) | IL133234A (xx) |
IS (1) | IS1943B (xx) |
MY (1) | MY117960A (xx) |
NO (1) | NO995853L (xx) |
NZ (1) | NZ501075A (xx) |
PL (1) | PL337181A1 (xx) |
PT (1) | PT984952E (xx) |
RU (1) | RU2193560C2 (xx) |
SE (1) | SE510305C2 (xx) |
SK (1) | SK282755B6 (xx) |
TR (1) | TR199902926T2 (xx) |
TW (1) | TW510899B (xx) |
UA (1) | UA53720C2 (xx) |
WO (1) | WO1998054166A1 (xx) |
YU (1) | YU62499A (xx) |
ZA (1) | ZA984486B (xx) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0102888D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
SE0102887D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
SE0102886D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
SE0301796D0 (sv) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use II |
SE0301795D0 (sv) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use I |
EP2022110B1 (en) * | 2006-05-11 | 2011-10-12 | Johnson Controls Saft Advanced Power Solutions LLC | Modular battery system |
JP5163931B2 (ja) * | 2007-03-08 | 2013-03-13 | 株式会社リコー | 定着装置及び画像形成装置 |
EP2065385A1 (en) * | 2007-11-28 | 2009-06-03 | Laboratorios SALVAT, S.A. | Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester |
CN101747305B (zh) * | 2008-11-28 | 2014-06-18 | 中国医学科学院药物研究所 | 硝克柳胺化合物晶v型、其制法和其药物组合物与用途 |
LT2989095T (lt) * | 2013-04-26 | 2019-03-12 | Sanofi | 5-chlortiofen-2-karboksirūgšties [(s)-2-[metil-3-(2-okso-pirolidin-1-il)-benzensulfonilamino]-3-(4-metilpiperazin-1 -il)-3-oksopropil]amido tartrato druska |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5420151A (en) * | 1989-12-22 | 1995-05-30 | Aktiebolaget Astra | Chroman derivatives |
US5616610A (en) * | 1989-12-22 | 1997-04-01 | Astra Aktiebolag | (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans |
US5990114A (en) * | 1996-02-28 | 1999-11-23 | Recordati, S.A., Chemical And Pharmaceutical Company | Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence |
IT1282705B1 (it) | 1996-02-28 | 1998-03-31 | Recordati Chem Pharm | Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria |
-
1997
- 1997-05-30 SE SE9702066A patent/SE510305C2/sv not_active IP Right Cessation
-
1998
- 1998-05-13 TW TW087107397A patent/TW510899B/zh active
- 1998-05-15 PL PL98337181A patent/PL337181A1/xx unknown
- 1998-05-15 CN CNB988056631A patent/CN1198814C/zh not_active Expired - Fee Related
- 1998-05-15 HU HU0001878A patent/HUP0001878A3/hu unknown
- 1998-05-15 AU AU77923/98A patent/AU729301B2/en not_active Ceased
- 1998-05-15 NZ NZ501075A patent/NZ501075A/en unknown
- 1998-05-15 EP EP98925993A patent/EP0984952B1/en not_active Expired - Lifetime
- 1998-05-15 YU YU62499A patent/YU62499A/sh unknown
- 1998-05-15 ID IDW991407A patent/ID23794A/id unknown
- 1998-05-15 US US09/077,718 patent/US6858645B2/en not_active Expired - Fee Related
- 1998-05-15 ES ES98925993T patent/ES2187030T3/es not_active Expired - Lifetime
- 1998-05-15 DK DK98925993T patent/DK0984952T3/da active
- 1998-05-15 CA CA002291732A patent/CA2291732C/en not_active Expired - Fee Related
- 1998-05-15 JP JP50056099A patent/JP3554338B2/ja not_active Expired - Fee Related
- 1998-05-15 WO PCT/SE1998/000907 patent/WO1998054166A1/en not_active Application Discontinuation
- 1998-05-15 UA UA99127241A patent/UA53720C2/uk unknown
- 1998-05-15 IL IL13323498A patent/IL133234A/en not_active IP Right Cessation
- 1998-05-15 PT PT98925993T patent/PT984952E/pt unknown
- 1998-05-15 TR TR1999/02926T patent/TR199902926T2/xx unknown
- 1998-05-15 SK SK1594-99A patent/SK282755B6/sk unknown
- 1998-05-15 BR BR9809519-6A patent/BR9809519A/pt not_active IP Right Cessation
- 1998-05-15 KR KR19997011107A patent/KR20010013127A/ko active IP Right Grant
- 1998-05-15 EE EEP199900549A patent/EE03874B1/xx not_active IP Right Cessation
- 1998-05-15 DE DE69809547T patent/DE69809547T2/de not_active Expired - Fee Related
- 1998-05-15 AT AT98925993T patent/ATE228121T1/de not_active IP Right Cessation
- 1998-05-15 RU RU99128026/04A patent/RU2193560C2/ru not_active IP Right Cessation
- 1998-05-26 AR ARP980102434A patent/AR012751A1/es unknown
- 1998-05-26 ZA ZA984486A patent/ZA984486B/xx unknown
- 1998-05-29 MY MYPI98002400A patent/MY117960A/en unknown
-
1999
- 1999-11-24 IS IS5270A patent/IS1943B/is unknown
- 1999-11-29 NO NO995853A patent/NO995853L/no not_active Application Discontinuation
- 1999-12-03 BG BG103949A patent/BG64051B1/bg unknown
-
2000
- 2000-08-08 HK HK00104934A patent/HK1025575A1/xx not_active IP Right Cessation
-
2004
- 2004-10-12 US US10/964,388 patent/US20050085532A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10844058B2 (en) | Valbenazine salts and polymorphs thereof | |
EP1818329B1 (en) | (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2methyl-1,4homopiperazine hydrochloride dihydrate | |
EP1440969A1 (en) | Alpha-form or beta-form crystal of acetanilide derivative | |
NO341013B1 (no) | Fremgangsmåte for fremstilling av atazanavirbisulfat,og former derav | |
US9856270B2 (en) | Dolutegravir salts | |
SE510305C2 (sv) | Nytt salt | |
KR101319516B1 (ko) | 퓨린 유도체 | |
KR101710740B1 (ko) | 2-[[[2-[(히드록시아세틸)아미노]-4-피리디닐]메틸]티오]-n-[4-(트리플루오로메톡시)페닐]-3-피리딘카르복사미드의 벤젠술폰산염, 이의 결정, 이의 결정 다형 및 이들의 제조 방법 | |
KR101557832B1 (ko) | (r)-3-플루오로페닐-3,4,5-트리플루오로벤질카르밤산 1-아자비시클로 [2.2.2]옥트-3-일 에스테르의 안정한 결정성 염 | |
KR101653816B1 (ko) | 결정형 사포그릴레이트 옥살산염 일수화물 또는 이의 무수물 | |
KR100372964B1 (ko) | 피페리딘유도체결정,이의제조용중간생성물및이의제조방법 | |
KR101423630B1 (ko) | 비칼루타미드와 니코틴아미드의 공결정 | |
WO2020042903A1 (zh) | 一种环己烷衍生物的盐 | |
US10870627B2 (en) | Salt of quinazoline derivative, preparation method therefor and application thereof | |
CZ426199A3 (cs) | Nová sůl | |
MXPA99010942A (en) | A new salt | |
TW202216726A (zh) | 八氫噻吩并喹啉化合物之琥珀酸鹽及其結晶 | |
CN112851641A (zh) | 嘧啶苯甲酰胺化合物的盐酸盐及其用途 | |
EA043769B1 (ru) | Соли валбеназина и их полиморфы |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |